PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

23 Dec 2013 13:40

RNS Number : 2475W
Deltex Medical Group PLC
23 December 2013
 
Deltex Medical Group plc

 

Directors' Shareholdings/Issue of equity

 

 

23 December 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 790,574 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 14.00 pence per share.

 

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 October 2012 to 31 December 2013.

 

Paul Mitchell, Finance Director has elected to take New Ordinary Shares in lieu of £20,000 of salary in respect of the period 1 January 2013 to 31 December 2013.

 

In addition to the above, the Company also announces that it has today issued a total of 71,429 New Ordinary Shares to a former employee of the Company at a price of 14.00 pence per share in settlement of contractual obligations.

 

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 31 December 2013. Following the issue of these new shares the Company has a total of 168,070,379 ordinary shares of 1p each in issue.

 

Following this issue, the directors' beneficial interests are as follows:

 

 

Name of Director

Number of New Ordinary Shares issued in lieu of fees/salary

 

Holding of shares following issue of New Ordinary Shares

 

% of enlarged issued share capital

Nigel Keen

297,616

6,985,163

4.16

Dr Edwin Snape

214,286

1,430,624

0.85

Sir Duncan Nichol

75,000

928,916

0.55

Julian Cazalet

49,386

4,080,268

2.43

Paul Mitchell

82,857

352,831

0.21

 

For further information:

 

Deltex Medical Group plc

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman

 

Ewan Phillips, Chief Executive

 

Paul Mitchell, Finance Director

 

 

 

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

Financial Public Relations

Newgate Threadneedle

020 7653 9850

Graham Herring

Caroline Evans-Jones

Heather Armstrong

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEIFDDFDSEDE
Date   Source Headline
25th Oct 20133:01 pmRNSHolding(s) in Company
23rd Oct 20137:00 amRNSAdditional Dedicated Trainer Hospital in USA
23rd Oct 20137:00 amRNSFDA approves CardioQ-ODM+
23rd Sep 20137:00 amRNSPrivate Investor Event
10th Sep 20137:00 amRNSInterim Results
8th Aug 20137:00 amRNSNotice of Results
1st Aug 20137:00 amRNSUS Authorities Publish ODM Payment Instructions
26th Jul 20133:02 pmRNSAdditional Listing
9th Jul 20139:00 amRNSPre-Close Update
4th Jul 20137:00 amRNSPositive Study from St Thomas's Hospital
25th Jun 201311:30 amRNSIssue of Equity
25th Jun 201311:10 amRNSDirector/PDMR Shareholding
24th Jun 20137:00 amRNSFDA submission completed for CardioQ-ODM+
19th Jun 20137:00 amRNSPremier Update: Successful Pilot Study
18th Jun 20134:11 pmRNSManchester One2One Investors Forum - June 26
30th May 20137:00 amRNSClinical Guidelines for Anaesthetists in France
17th May 201310:25 amRNSDirector/PDMR Shareholding
1st May 20138:47 amRNSResult of AGM
30th Apr 20137:00 amRNSAGM Statement
24th Apr 20135:44 pmRNSHolding(s) in Company
23rd Apr 20138:51 amRNSHolding(s) in Company
12th Apr 20133:23 pmRNSDirector Shareholding and Additional Listing
12th Apr 201312:42 pmRNSDirector/PDMR Shareholding - Replacement
12th Apr 20137:00 amRNSDirector/PDMR Shareholding
10th Apr 20137:00 amRNSUS Govt body grants unique payment code for ODM
25th Mar 20137:00 amRNSFinal Results
18th Mar 20137:00 amRNSOutstanding Achievement Award
4th Feb 20131:42 pmRNSHolding(s) in Company
28th Jan 201310:06 amRNSHolding(s) in Company
23rd Jan 201312:39 pmRNSDirector/PDMR Shareholding
18th Jan 201311:20 amRNSPlacing to raise £2.5 million
8th Jan 20137:00 amRNSPre-close update
24th Dec 20127:00 amRNSNHS sets requirements for Fluid Management
10th Dec 20127:00 amRNSNew study supports the importance of ODM
29th Nov 20127:00 amRNSStudy reinforces CardioQ-ODM competitive advantage
31st Oct 20129:52 amRNSDirector/PDMR Shareholding
25th Oct 20124:47 pmRNSAdditional Listing
23rd Oct 20127:00 amRNSNHS South Innovation Plan
19th Oct 20127:00 amRNSEnhanced Recovery Update
10th Oct 20124:25 pmRNSGrant of options
10th Oct 20124:23 pmRNSIssue of Equity and TVR
19th Sep 20127:00 amRNSInterim Results
9th Aug 20128:23 amRNSHolding(s) in Company
6th Jul 20127:00 amRNSPre-close update on six months ended 30 June 2012
3rd Jul 20127:00 amRNSERP backs wide adoption of CardioQ-ODM
29th Jun 201210:13 amRNSDirector/PDMR Shareholding
22nd May 20124:54 pmRNSIssue of Equity
2nd May 20121:00 pmRNSResult of AGM
16th Apr 20129:35 amRNSHolding(s) in Company (Replacement to 10/04/12)
16th Apr 20129:23 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.